Josh Fradkoff
Vice President Finance, Quantum-Si
Professional Overview:
Josh Fradkoff is an accomplished finance executive with over 15 years of experience driving strategic financial initiatives and delivering operational excellence across the healthcare and life sciences industries. As the Vice President of Finance at Quantum-Si, he oversees the company's financial operations, including budgeting, forecasting, and reporting, to ensure the efficient allocation of resources and support the organization's growth and innovation.
Experience Summary:
Current Role:
As the Vice President of Finance at Quantum-Si, a leading provider of next-generation semiconductor-based detection and sequencing technologies, Josh is responsible for the company's financial planning, analysis, and reporting. He plays a crucial role in aligning the company's financial strategy with its overall business objectives, streamlining processes, and optimizing financial performance to support Quantum-Si's mission of revolutionizing the field of biological research and diagnostics.
Career Progression:
Prior to joining Quantum-Si, Josh served as the VP, CFO of Pharma Services at NeoGenomics Laboratories, where he led the financial operations of the company's Pharma Services division and played a pivotal role in the successful integration of several strategic acquisitions. Before that, he held senior finance roles at BD, including Senior Director of Finance for the US Region and Senior Director of Finance, where he drove financial planning, analysis, and reporting initiatives to support the company's growth and operational efficiency.
Academic Background:
Josh holds a Bachelor of Science degree in Accounting from the University of California, San Diego, and a Master of Business Administration from the University of Southern California.
Areas of Expertise:
- Financial planning and analysis
- Strategic cost management
- Financial reporting and control
- Mergers and acquisitions integration
- Business process optimization
- Financial systems implementation and optimization
Professional Impact:
During his tenure at NeoGenomics Laboratories, Josh played a key role in the successful integration of several strategic acquisitions, driving synergies and improving financial performance. At BD, he led the implementation of a new financial reporting system, which enhanced data visibility and enabled more informed decision-making. Josh's expertise in financial management, combined with his strong strategic and operational leadership skills, have consistently contributed to the success of the organizations he has served.
Conclusion:
With his extensive experience in the healthcare and life sciences industries, Josh Fradkoff is well-positioned to drive Quantum-Si's financial strategy and support the company's mission of advancing the field of biological research and diagnostics. His proven track record of financial management, process optimization, and strategic leadership make him a valuable asset to the Quantum-Si team.